DBU

Company Description:IRIS Biotech was established in 2001. Our portfolio consists of more some 4500 items and we supply products for drug discovery, drug delivery and biocatalysis from lab scale for R&D to multi-ton lots for commercial productions. This includes starting materials for peptide synthesis and other areas of medicinal chemistry, solid phase organic synthesis, life sciences research. We have with more than 400 reagents for PEGylation, from short monodisperse to long polydisperse space... View more >>